CDC Logo Skip Top Nav
 CDC Home PageSearch the CDCHealth Topics A though Z
Division of Tuberculosis Elimination
About DTBE Upcoming Events Site Map CDC en Espanol Contact Us
Skip the Contents menu


Skip the Resources menu


U.S. Department of Health and Human Services

Fact Sheets

Return to Fact Sheets Main Menu
(PDF - 94k)

Recommendations for Human Immunodeficiency Virus (HIV) Screening in Tuberculosis (TB) Clinics
Updated: April 2008

What are the recommendations for human immunodeficiency virus (HIV) screening in tuberculosis (TB) clinics?

In revised recommendations from 2006, CDC recommends HIV screening for all TB patients after the patient is notified that testing will be performed, unless the patient declines (i.e., opt-out screening). Routine HIV testing is also recommended for persons suspected of having TB disease and contacts to TB patients. Persons at high risk for HIV infection should be screened for HIV at least annually. Prevention counseling and separate written consent for HIV testing should no longer be required.

How do the new 2006 recommendations for HIV screening differ from previous ones?

These recommendations only address health care settings and do not replace previous recommendations for HIV testing in non-clinical, outreach, or field settings. The recommendations are aimed to eliminate missed opportunities for HIV screening and reduce significant barriers to HIV testing in health care settings by

  • Using opt-out HIV screening;
  • Annually screening persons at high risk for HIV;
  • Eliminating the need for separate written consent for HIV testing; and
  • Eliminating the need for prevention counseling as part of routine HIV screening.

What is opt-out screening?

Opt-out screening is defined as performing HIV testing after notifying the patient that the test will be performed, and although the patient may decline or defer testing, it is strongly recommended. Assent is inferred unless the patient declines testing.

Why does CDC recommend that TB clinics screen their patients for HIV infection?

HIV infection is the most important known risk factor for progression from latent TB infection to TB disease. Progression to TB disease is often rapid among HIV-infected persons and can be deadly. In addition, TB outbreaks can rapidly expand in HIV-infected patient groups.

Targeted HIV testing based on provider assessment of patient risk behaviors fails to identify a substantial number of persons who are HIV infected. This is because many individuals may not perceive themselves to be at risk for HIV or do not disclose their risks. Routine HIV testing also reduces the stigma associated with testing.

When HIV is diagnosed early, appropriately timed interventions can lead to improved health outcomes, including slower progression and reduced mortality. Identifying TB patients, suspects, and contacts who are HIV infected allows for optimal TB testing of these groups and provides opportunities to prevent TB in those without disease.

Who should be tested for HIV in TB clinics?

All patients in TB clinics should be tested for HIV. This includes TB suspects, patients, and contacts.

Can rapid HIV tests be used to screen TB patients and their contacts?

Yes. Rapid HIV tests, using fingerprick or oral specimens, can be used. Results are available in about 20 minutes. Although the rapid HIV test kits cost about $10 more per test than standard lab assays, they have been shown to be cost-effective and to increase patients’ acceptance of HIV testing. Another option is to collect oral swab specimens and use standard lab assays.

What education and training resources on HIV counseling and testing are available?

Resources for education and training on HIV counseling and testing are available from CDC-funded HIV/AIDS programs in each state health department, and from the National Network of STD/HIV Prevention Training Centers. Additionally, the Health Resources and Services Administration (HRSA) has regional AIDS Education and Training Centers (AETCs) and other local performance sites that can provide training in HIV counseling and testing to TB staff.

Also available is a Contact Investigation and Management Protocol to facilitate HIV counseling, testing, and referral during TB contact investigations. The protocol was developed by the New York City Bureau of TB Control, in collaboration with the New York City Department of Health HIV Training Institute, with funding from CDC.

Additional Information



Last Modified: 04/30/2008

Last Reviewed: 05/18/2008
Content Source: Division of Tuberculosis Elimination
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention


Back to Top of Page

If you would like to order any of the DTBE publications please visit the online order form.

You will need Adobe Acrobat™ Reader v5.0 or higher to read pages that are in PDF format.  Download the Adobe Acrobat™ Reader.

If you have difficulty accessing any material on the DTBE Web site because of a disability, please contact us in writing or via telephone and we will work with you to make the information available.

Division of Tuberculosis Elimination
Attn: Content Manager, DTBE Web site
Centers for Disease Control and Prevention
1600 Clifton Rd., NE Mailstop E-10
Atlanta, GA 30333
CDC-INFO at (1-800) 232-4636
TTY: 1 (888) 232-6348

Skip Bottom Nav Home | Site Map | Contact Us
Accessibility | Privacy Policy Notice | FOIA |
CDC Home | Search | Health Topics A-Z

Centers for Disease Control & Prevention
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
Division of Tuberculosis Elimination
Please send comments/suggestions/requests to: